CTRL Therapeutics operates a biotechnology company that researches cell therapy and treatment.
CTRL Therapeutics has raised $9.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.
CTRL Therapeutics's investors include General Catalyst, Intermountain Healthcare, FACIT.
CTRL Therapeutics is headquartered in Toronto, Canada.
CTRL Therapeutics operates a biotechnology company that researches cell therapy and treatment.
CTRL Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CTRL Therapeutics — Funding & Investors." VCBacked, September 26, 2024, https://www.vcbacked.co/company/ctrl-therapeutics. Accessed September 29, 2026.
VCBacked. (2024). CTRL Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/ctrl-therapeutics
{{cite web |title=CTRL Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ctrl-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated